Real-time enrollment status for this generalized anxiety disorder clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:34 PM UTC
| NCT Number | NCT06701903 |
| Recruiting Status | Recruiting |
| Condition | Generalized Anxiety Disorder |
| Phase | PHASE2 |
| Target Enrollment | 570 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Intra-Cellular Therapies, Inc. |
| Last Updated on CT.gov | January 9, 2026 (Jan 9, 2026) |
As of July 17, 2026: Clinical trial NCT06701903 is currently recruiting participants. This phase2 study for generalized anxiety disorder is actively seeking new participants at 30 locations across the United States. The study is sponsored by Intra-Cellular Therapies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06701903 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06701903 was last updated Jan 9, 2026 (January 9, 2026). HelloStudys verifies this status automatically.